{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:10:43Z","timestamp":1791483043236,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1124\/jpet.113.207621","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T05:14:53Z","timestamp":1375938893000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Olanzapine Activates Hepatic Mammalian Target of Rapamycin: New Mechanistic Insight into Metabolic Dysregulation with Atypical Antipsychotic Drugs"],"prefix":"10.1016","volume":"347","author":[{"given":"Robin H.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny D.","family":"Jokinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica L.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Cameron","family":"Falkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane I.","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin E.","family":"Arteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.207621_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/schbul\/sbq053","article-title":"Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents","volume":"38","author":"Albaugh","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1124\/jpet.113.207621_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.amepre.2008.11.020","article-title":"Obesity among those with mental disorders: a National Institute of Mental Health meeting report","volume":"36","author":"Allison","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1124\/jpet.113.207621_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbrc.2012.03.109","article-title":"Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR","volume":"421","author":"Almilaji","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.113.207621_bib4","doi-asserted-by":"crossref","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","article-title":"Evaluating the glucose tolerance test in mice","volume":"295","author":"Andrikopoulos","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.113.207621_bib5","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1053\/j.gastro.2006.03.020","article-title":"Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1","volume":"130","author":"Bergheim","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.113.207621_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1124\/jpet.113.207621_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","article-title":"Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration","volume":"28","author":"Chintoh","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.113.207621_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","article-title":"Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design","volume":"127","author":"Coccurello","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.113.207621_bib9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.ijo.0802928","article-title":"Antipsychotic drug-induced weight gain: development of an animal model","volume":"29","author":"Cope","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1124\/jpet.113.207621_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.113.207621_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4321\/S1130-01082012001100017","article-title":"Liver toxicity due to olanzapine","volume":"104","author":"Dom\u00ednguez-Jim\u00e9nez","year":"2012","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1124\/jpet.113.207621_bib12","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4088\/JCP.09m05274yel","article-title":"The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis","volume":"71","author":"Ehret","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.113.207621_bib13","doi-asserted-by":"crossref","first-page":"e43244","DOI":"10.1371\/journal.pone.0043244","article-title":"Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance","volume":"7","author":"Girault","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.113.207621_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3325\/cmj.2011.52.41","article-title":"Blood lactate levels in patients receiving first- or second- generation antipsychotics","volume":"52","author":"Glavina","year":"2011","journal-title":"Croat Med J"},{"key":"10.1124\/jpet.113.207621_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0006-3223(01)01321-X","article-title":"Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine","volume":"51","author":"Goff","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.113.207621_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrn3409","article-title":"Wired on sugar: the role of the CNS in the regulation of glucose homeostasis","volume":"14","author":"Grayson","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.113.207621_bib17","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/scisignal.267pe24","article-title":"The pharmacology of mTOR inhibition","volume":"2","author":"Guertin","year":"2009","journal-title":"Sci Signal"},{"key":"10.1124\/jpet.113.207621_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev Cell"},{"key":"10.1124\/jpet.113.207621_bib19","doi-asserted-by":"crossref","first-page":"26457","DOI":"10.1074\/jbc.272.42.26457","article-title":"Regulation of eIF-4E BP1 phosphorylation by mTOR","volume":"272","author":"Hara","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.207621_bib20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.113.207621_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v64n0513","article-title":"Metabolic syndrome in patients with schizophrenia","volume":"64","author":"Heiskanen","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.113.207621_bib22","first-page":"336","article-title":"Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers","volume":"31","author":"Hroudova","year":"2010","journal-title":"Neuroendocrinol Lett"},{"key":"10.1124\/jpet.113.207621_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1074\/jbc.M109.048777","article-title":"Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm)","volume":"285","author":"Islam","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.207621_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.207621_bib25","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"From the cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.113.207621_bib26","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1249\/01.mss.0000233796.16411.13","article-title":"Interaction between the AMP-activated protein kinase and mTOR signaling pathways","volume":"38","author":"Kimball","year":"2006","journal-title":"Med Sci Sports Exerc"},{"key":"10.1124\/jpet.113.207621_bib27","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1046\/j.1432-1033.2002.03074.x","article-title":"Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes","volume":"269","author":"Krause","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1124\/jpet.113.207621_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1124\/jpet.113.207621_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4088\/JCP.v63n0706","article-title":"Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific","volume":"63","author":"Lee","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.113.207621_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","article-title":"Hepatic histology in obese patients undergoing bariatric surgery","volume":"45","author":"Machado","year":"2006","journal-title":"J Hepatol"},{"issue":"5, Suppl B","key":"10.1124\/jpet.113.207621_bib31","first-page":"S1","article-title":"Summary of the comparative effectiveness review on off-label use of atypical antipsychotics","volume":"18","author":"Maher","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1124\/jpet.113.207621_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","article-title":"Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants","volume":"97","author":"Marroquin","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.113.207621_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3949\/ccjm.74.8.597","article-title":"Atypical antipsychotics: new drugs, new challenges","volume":"74","author":"Mathews","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"10.1124\/jpet.113.207621_bib34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"10.1124\/jpet.113.207621_bib35","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States, 1999\u20132004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1124\/jpet.113.207621_bib36","doi-asserted-by":"crossref","first-page":"E624","DOI":"10.1152\/ajpendo.00502.2010","article-title":"Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism","volume":"300","author":"Oh","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.113.207621_bib37","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","article-title":"Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis","volume":"35","author":"Ratziu","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/jpet.113.207621_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrd2874","article-title":"Targeting the CNS to treat type 2 diabetes","volume":"8","author":"Sandoval","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.207621_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.113.207621_bib40","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1074\/jbc.M110.166991","article-title":"Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K\/Akt signaling","volume":"286","author":"Tato","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.207621_bib41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.pharmtox.42.082701.160735","article-title":"Glutamatergic mechanisms in schizophrenia","volume":"42","author":"Tsai","year":"2002","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.113.207621_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases","volume":"12","author":"Tsang","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.113.207621_bib43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2007.11.078","article-title":"Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution","volume":"585","author":"van der Zwaal","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.207621_bib44","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1515\/bchm2.1967.348.1.1686","article-title":"Uber Wachstum von Krebszellen in Medien, deren Glucose durch Galaktose ersetzt ist","volume":"348","author":"Warburg","year":"1967","journal-title":"Hoppe Seylers Z Physiol Chem"},{"key":"10.1124\/jpet.113.207621_bib45","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/bioinformatics\/btt275","article-title":"MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics","volume":"29","author":"Wei","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1124\/jpet.113.207621_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1124\/jpet.113.207621_bib47","doi-asserted-by":"crossref","first-page":"e33548","DOI":"10.1371\/journal.pone.0033548","article-title":"Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain","volume":"7","author":"Weston-Green","year":"2012","journal-title":"PLoS ONE"},{"issue":"6, Suppl","key":"10.1124\/jpet.113.207621_bib48","doi-asserted-by":"crossref","first-page":"1531S","DOI":"10.1093\/jn\/135.6.1531S","article-title":"Brain amino acid requirements and toxicity: the example of leucine","volume":"135","author":"Yudkoff","year":"2005","journal-title":"J Nutr"},{"key":"10.1124\/jpet.113.207621_bib49","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1016\/j.chroma.2011.07.039","article-title":"iMatch: a retention index tool for analysis of gas chromatography-mass spectrometry data","volume":"1218","author":"Zhang","year":"2011","journal-title":"J Chromatogr A"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524287693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524287693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.207621","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:17:28Z","timestamp":1739996248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524287693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0022356524287693"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.207621","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine Activates Hepatic Mammalian Target of Rapamycin: New Mechanistic Insight into Metabolic Dysregulation with Atypical Antipsychotic Drugs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.207621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}